| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/14/2007 | CN1930288A Cells of which genome is modified |
| 03/14/2007 | CN1930180A L-saccharide glucose lipid a analogue |
| 03/14/2007 | CN1930162A Tetrahydropyridoindole derivatives |
| 03/14/2007 | CN1930160A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 03/14/2007 | CN1929855A Method of inducing or modulating immune response |
| 03/14/2007 | CN1928107A Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla) |
| 03/14/2007 | CN1927879A Thymopentapeptide active isomer and application thereof in pharmaceutical preparation |
| 03/14/2007 | CN1927403A Medicine for promoting pigling growth and improving pigling immunity and preparing method thereof |
| 03/14/2007 | CN1927397A Extraction method of animal blood plasma immunoglobulin oral administration preparation |
| 03/14/2007 | CN1927387A Application of interleukins-15 in preparation of medicine for tumor immunization therapy and immunotherapy drug |
| 03/14/2007 | CN1927360A Traditional Chinese medicine composition for treating skin inflammation |
| 03/14/2007 | CN1927356A Oxidation resistance functional form health food for enhancing human body immunity |
| 03/14/2007 | CN1927279A Chinese medicine composition for treating skin disease |
| 03/14/2007 | CN1927209A Compositions for inhibiting or reducing inflammation of skin |
| 03/14/2007 | CN1927196A Preparing process for freeze-dried calcium gluconate powder injection |
| 03/14/2007 | CN1927168A Implantation slow release medicine in eyes |
| 03/14/2007 | CN1927137A Pre-transplant accommodated organs resistant to anti-donor immunity |
| 03/14/2007 | CN1304548C Health care wine containing dihydro-myricetin and myricetin composition |
| 03/14/2007 | CN1304425C Fusion protein containing soluble tumor necrosis factor II type receptor and interleukin I receptor agonist IL1Ra its preparation process and medicine composition |
| 03/14/2007 | CN1304421C Peptides having affinity for the GP 120 viral protein and use thereof |
| 03/14/2007 | CN1304389C Piperidine derivatives useful as CCR5 antagonists |
| 03/14/2007 | CN1304383C Benzothiazole derivatives |
| 03/14/2007 | CN1304382C New p2X* receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases |
| 03/14/2007 | CN1304379C Water-soluble phenylpyridazine compounds and compositions containing the same |
| 03/14/2007 | CN1304377C Metalloproteinase inhibitors |
| 03/14/2007 | CN1304375C Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions |
| 03/14/2007 | CN1304058C Water soluble paclitaxel prodrugs |
| 03/14/2007 | CN1304052C Medicinal compositions for application to mucosa |
| 03/14/2007 | CN1304051C PSGL-1 regulator |
| 03/14/2007 | CN1304013C Garnoderma product and its preparing process |
| 03/14/2007 | CN1304011C Method for the protection of endothelial and epithclial cells during chemotherapy |
| 03/14/2007 | CN1304009C Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 03/14/2007 | CN1304008C Medical compsns. |
| 03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |
| 03/13/2007 | US7189837 Cell surface molecule-induced macrophage activation |
| 03/13/2007 | US7189827 Fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides; recombinant proteins |
| 03/13/2007 | US7189826 Hybridomas cell lines; viricides |
| 03/13/2007 | US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases |
| 03/13/2007 | US7189816 Antibody having a binding structure comprising specified complementarity determining region (CDR) sequences for a target tumor antigen on human gastrointestinal epithelial tumour cells; colon cancer diagnosis or immunotherapy |
| 03/13/2007 | US7189808 Use of carboxy-terminal fragment of Ki-67 protein or of an active part, fragment or homologue thereof as compound that can be used for intracellular transfer and for introduction into and release by cells; antiinflammatory, anticancer agents |
| 03/13/2007 | US7189801 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |
| 03/13/2007 | US7189758 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 03/13/2007 | US7189756 Pyrrolidine derivatives |
| 03/13/2007 | US7189751 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 03/13/2007 | US7189742 For therapy of disorder associated with elevated levels of 5-HT (5-hydroxytryptamine; serotonin) resultant from newly synthesised 5-HT, anxiety, depression, migraine and sleep apnoea |
| 03/13/2007 | US7189741 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 03/13/2007 | US7189739 Antiinflammatory agents; cardiovascular disorders; rheumatic disorders |
| 03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
| 03/13/2007 | US7189723 Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity |
| 03/13/2007 | US7189719 Sodium channel blockers |
| 03/13/2007 | US7189713 Piperidine derivatives |
| 03/13/2007 | US7189696 Peptide antagonists of zonulin and methods for use of the same |
| 03/13/2007 | US7189536 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus |
| 03/13/2007 | US7189525 Human enzymes of the metalloprotease family |
| 03/13/2007 | US7189517 Goodpasture antigen binding protein |
| 03/13/2007 | US7189390 Probiotics for pet food applications |
| 03/13/2007 | US7189389 Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes |
| 03/13/2007 | CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 03/13/2007 | CA2387533C Purine derivatives |
| 03/13/2007 | CA2240494C Therapeutic molecules generated by trans-splicing |
| 03/13/2007 | CA1341522C Novel granulocyte colony stimulating factor polypeptide derivatives |
| 03/09/2007 | CA2559439A1 Compositions for inhibiting or reducing inflammation of skin |
| 03/09/2007 | CA2559279A1 Compositions for inhibiting or reducing inflammation of skin |
| 03/08/2007 | WO2007028129A1 Hydroxy substituted 1h-imidazopyridines and methods |
| 03/08/2007 | WO2007027729A1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases |
| 03/08/2007 | WO2007027714A2 Engineered anti-il-23 antibodies |
| 03/08/2007 | WO2007027594A1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases |
| 03/08/2007 | WO2007027528A2 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases |
| 03/08/2007 | WO2007027132A1 Treatment of inflammatory bowel disease |
| 03/08/2007 | WO2007026966A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | WO2007026836A1 Novel therapeutic agent derived from marine organism |
| 03/08/2007 | WO2007026720A1 Ring-fused pyrazole derivative |
| 03/08/2007 | WO2007025751A1 Use of fused imidazole derivatives to mediate ccr3 related conditions |
| 03/08/2007 | WO2007025534A1 Fredericamycin derivatives |
| 03/08/2007 | WO2007025365A1 Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms |
| 03/08/2007 | WO2007025343A1 Modified chaperonin 10 |
| 03/08/2007 | WO2007011216A3 Bifunctional protein anchors |
| 03/08/2007 | WO2007011216A2 Bifunctional protein anchors |
| 03/08/2007 | WO2006120575A3 Tcr-independent activation of t cells with co-lignation of cd28 and cd81 |
| 03/08/2007 | WO2006108572A3 Novel crystalline pharmaceutical product |
| 03/08/2007 | US20070054950 3-Azabicyclo[3.1.0]hexane derivatives |
| 03/08/2007 | US20070054913 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
| 03/08/2007 | US20070054902 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists |
| 03/08/2007 | US20070054364 Polypeptide variants |
| 03/08/2007 | US20070054312 Human transmembrane proteins |
| 03/08/2007 | US20070053915 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein |
| 03/08/2007 | DE102005041760A1 New fredericamycin A derivatives with carbon-bonded B-ring substituent, are well tolerated topoisomerase I and/or II inhibitors especially useful for treating cancers or tumors |
| 03/08/2007 | CA2825762A1 Method for enhancing anti-neoplastic activity of an oncolytic virus using modified dendritic cells |
| 03/08/2007 | CA2621136A1 Immunological uses of immunodulatory compounds for vaccine and anti-infectious disease therapy |
| 03/08/2007 | CA2621127A1 Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms |
| 03/08/2007 | CA2621083A1 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins |
| 03/08/2007 | CA2620933A1 Hydroxy substituted 1h-imidazopyridines and methods |
| 03/08/2007 | CA2620834A1 Use of fused imidazole derivatives to mediate ccr3 related conditions |
| 03/08/2007 | CA2620802A1 Engineered anti-il-23 antibodies |
| 03/08/2007 | CA2620742A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | CA2620729A1 Modified chaperonin 10 |
| 03/08/2007 | CA2620631A1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases |
| 03/08/2007 | CA2620352A1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases |
| 03/08/2007 | CA2620269A1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases |